Distribution of sertraline in postmortem cases

Journal of Analytical Toxicology

Volumn 18, Issue 5, 1994, Pages 272-274

  Levine, Barry ^a   Jenkins, Amanda J ^a   Smialek, John E ^a  

^a OFFICE OF THE CHIEF MEDICAL EXAMINER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ARTICLE; CADAVER; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG LIVER LEVEL; DRUG SCREENING; GAS CHROMATOGRAPHY; MASS SPECTROMETRY;

1-NAPHTHYLAMINE; ADULT; AGED; ANTIDEPRESSIVE AGENTS; CHROMATOGRAPHY, GAS; FEMALE; HUMAN; MALE; MIDDLE AGE; RETROSPECTIVE STUDIES; SERTRALINE; TISSUE DISTRIBUTION;

EID: 0027994080     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/18.5.272     Document Type: Letter

References (5)

1. S. Warrington. Clinical implications of the pharmacology of sertraline. Int. Clin. Psychopharmacol. 6 (Suppl. 2): 11-21 (1991).
2. D. Murdoch and D. McTavish. Sertraline: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 44: 604-24 (1992).
3. R. Baselt and R. Cravey. Disposition of Toxic Drugs and Chemicals in Man, 3rd ed. Year Book Medical Publishers, Chicago, IL, 1989.
4. F. Apple and C. Bandt. Liver and blood postmortem tricyclic antidepressant concentrations. Am. Clin. Pathol. 89:794-96 (1988).
5. B. Logan, G. Case, and P. Friel. Detection and characterization of sertraline (Zoloft) in a suicidal hanging and four other sertraline related fatalities. Presented at the 45th Annual American Academy of Forensic Sciences Meeting, Boston, MA, February, 1993.